Biomarkers Based EArly Diagnosis of STroke Subtype Cohort(Bio-EAST) (Bio-EAST)
Biomarkers Based EArly Diagnosis of STroke Subtype Cohort, Bio-EAST
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Gang Li
- Phone Number: +86 136 2169 1786
- Email: ligang@tongji.edu.cn
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200123
- Recruiting
- Shanghai East Hospital
-
Contact:
- Chen Chen, MD, PhD
- Phone Number: 86 15921119641
- Email: 15921119641@163.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years old;
- Suspected stroke at emergency department arrival (FAST score ≥ 2 points, must include limb weakness);
- Time of stroke symptom onset/last known normal within 3 hours.
Exclusion Criteria:
- Coma - no response to tactile or verbal stimuli;
- Severe comorbidities (such as tumors, severe COPD, severe heart failure, requiring assistance with daily living [unable to walk independently]);
- History of epilepsy or onset with seizure;
- Recent history of head trauma (< 7 days);
- Blood glucose < 2.8 mmol/L.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
intracranial hemorrhage, ICH
Patients diagnosed with hemorrhagic stroke by clinical gold standard.
Detect the peripheral blood biomarkers,and the results were compared with the clinical gold standard.
|
Peripheral blood samples were collected from patients suffering from acute stroke.
The concentration of the biomarker glial fibrillary acidic protein (GFAP) was then detected.
This was aimed at differentiating between hemorrhagic stroke and non - hemorrhagic stroke.
Time - concentration curves were constructed, thereby offering a novel potential approach for the rapid identification of stroke types within ambulances.
|
|
Non-hemorrhagic stroke
Patients diagnosed with non-hemorrhagic stroke by clinical gold standard.
Detect the peripheral blood biomarkers,and the results were compared with the clinical gold standard.
|
Peripheral blood samples were collected from patients suffering from acute stroke.
The concentration of the biomarker glial fibrillary acidic protein (GFAP) was then detected.
This was aimed at differentiating between hemorrhagic stroke and non - hemorrhagic stroke.
Time - concentration curves were constructed, thereby offering a novel potential approach for the rapid identification of stroke types within ambulances.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
stroke subtype
Time Frame: Upon arrival at the hospital for the first time
|
Cerebral hemorrhage diagnosed by head CT
|
Upon arrival at the hospital for the first time
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Bio-EAST
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.